220 related articles for article (PubMed ID: 24167609)
1. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
Wu M; Huang Z; Xie H; Zhou Z
PLoS One; 2013; 8(10):e78231. PubMed ID: 24167609
[TBL] [Abstract][Full Text] [Related]
2. Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials.
Shi L; Chen L; Qi G; Tian W; Zhao S
Am J Cardiovasc Drugs; 2020 Apr; 20(2):191-198. PubMed ID: 31423544
[TBL] [Abstract][Full Text] [Related]
3. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Ji Z; Zhang R; Lu W; Ma G; Qu Y
Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
[No Abstract] [Full Text] [Related]
5. Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis.
Zhou J; Xu J; Cheng A; Li P; Chen B; Sun S
J Int Med Res; 2020 Nov; 48(11):300060520967856. PubMed ID: 33249959
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
[No Abstract] [Full Text] [Related]
7. Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis.
Gao Q; Yang B; Guo Y; Zheng F
Medicine (Baltimore); 2015 Aug; 94(32):e1279. PubMed ID: 26266362
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
[TBL] [Abstract][Full Text] [Related]
9. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis.
Iwakura K; Ito H; Okamura A; Koyama Y; Date M; Higuchi Y; Inoue K; Kimura R; Nagai H; Imai M; Toyoshima Y; Ozawa M; Ito N; Okazaki Y; Shibuya M; Suenaga H; Kubota A; Fujii K
Circ J; 2009 May; 73(5):925-31. PubMed ID: 19325192
[TBL] [Abstract][Full Text] [Related]
10. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction.
Lee HC; An SG; Choi JH; Lee TK; Kim J; Kim JH; Chun KJ; Hong TJ; Shin YW; Lee SK
Circ J; 2008 Sep; 72(9):1425-9. PubMed ID: 18724016
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Geng N; Ren L; Xu L; Zou D; Pang W
BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
Zhao XT; Zhang CF; Liu QJ
BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
[TBL] [Abstract][Full Text] [Related]
14. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
Feng C; Liu Y; Wang L; Niu D; Han B
Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
[TBL] [Abstract][Full Text] [Related]
15. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
16. Effect of Chinese Medicine on No or Slow Reflow after Percutaneous Coronary Intervention in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.
Zhang XY; Sun Y; Yang XY; Hu JY; Zheng R; Chen SQ; Li M; Li CY; Jiang Y; Liu S; Zhao C; Xing YW; Shang HC
Chin J Integr Med; 2020 Mar; 26(3):227-234. PubMed ID: 31093877
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
Pang Z; Zhao W; Yao Z
Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
[TBL] [Abstract][Full Text] [Related]
18. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
Aung Naing K; Li L; Su Q; Wu T
Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
[TBL] [Abstract][Full Text] [Related]
19. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
[TBL] [Abstract][Full Text] [Related]
20. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
